ICON’s Acquisition of Symphony Clinical Research
The acquisition further enhances ICON’s patient, site and data strategy and complements ICON’s existing PMG Research and MeDiNova Research site networks in the US and EMEA.
ICON Reports Third Quarter 2019 Results
Quarter 3 reported revenue of $710.4 million. This represents strong year on year growth of 8.5% or 9.5% on a constant currency basis.
ICON plc to Present at Baird’s 2019 Global Healthcare Conference
Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present
ICON Reports Second Quarter 2019 Results
Net business wins (including pass-through) in the quarter of $901 million; a book to bill of 1.30.
ICON announces the appointment of Ms. Julie O’Neill to Board of Directors
And confirms the retirement of Professor Dermot Kelleher and Mr. Declan McKeon
Forbes names ICON in list of Best Employers in America for Women
ICON recognised as top employer for women in anonymous survey of 60,000 employees.
ICON and DIA driving Insights to Action with DIA Live 2019
DIA Live combines powerful AI analysis and data visualisation features of news and social media conversations at DIA Global Annual Meeting.
ICON’s Acquisition of MeDiNova Research
The acquisition further enhances ICON’s patient recruitment capabilities in EMEA and complements ICON’s existing site network in the US, PMG Research.
ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards
ICON Launches New Patient Engagement Platform to Support Improved Patient Experience & Enrolment in Clinical Trials
Increasing visibility of potential study participants to sites and sponsors.